USA: +1 617 939 9497 | UK: +44 2039 962936 | EU: +34 607 939 266 info@sofpromed.com
Select Page

CRO Change Orders: How Sponsors Can Control Them

Patricio Ledesma

Sofpromed's CEO and Founder. Global Director of Clinical Operations. 15+ years of experience in managing clinical trials.

18 November, 2026

Patricio Ledesma beside a CRO contract marked Change Order, illustrating sponsor cost control.

By Patricio Ledesma, Founder and CEO, Sofpromed

Table of Contents

I'm Patricio Ledesma.

Today I want to discuss something every biotech company faces.

Change orders.

At the beginning of a study.

The CRO budget looks reasonable.

Six months later.

The sponsor receives change order number ten.

Then number twenty.

Then number thirty.

Suddenly.

The study costs much more than expected.

Many sponsors believe CROs create change orders simply to increase revenue.

Sometimes that happens.

But often.

The real problem starts much earlier.

The root cause is usually:

  • Poor protocol planning.
  • Poor scope definition.
  • Poor contracts.
  • Poor governance.

Today I'll explain how CROs manage change orders.

How sponsors should negotiate them.

And how to avoid excessive change orders from the beginning.

What Is a Change Order?

A change order is a formal modification to the contract.

It typically changes:

  • Scope.
  • Timeline.
  • Resources.
  • Deliverables.
  • Budget.

Not every change order is unreasonable.

Some are unavoidable.

Others should never happen.

Typical CRO Change Order Categories

Table 1. Most common CRO change order sources

Category

Frequency

Preventable?

Protocol amendments

Very High

Partially

Enrollment delays

Very High

Partially

Additional sites

Very High

Yes

Additional countries

Medium

Yes

Additional monitoring visits

High

Yes

Database changes

High

Yes

Statistical outputs

Medium

Yes

Safety reporting increases

Medium

Partially

Vendor scope changes

High

Yes

Regulatory authority requests

Medium

No

Which Change Orders Are Fair?

Let's be fair.

Some change orders are legitimate.

Imagine:

The study starts with:

  • 20 sites.
  • 200 patients.
  • 3 countries.

Six months later.

The sponsor decides to add:

  • 15 more sites.
  • 2 more countries.
  • 100 additional patients.

The CRO's workload has increased substantially.

A change order is reasonable.

Most sponsors accept this.

Which Change Orders Are Concerning?

Now let's look at questionable situations.

Examples:

The CRO charges extra for:

  • Standard project management meetings.
  • Basic timeline updates.
  • Minor database modifications.
  • Clarification emails.
  • Routine status reports.

Sponsors should challenge these items.

Especially if the original scope was broad enough to include them.

Why CROs Like Change Orders

Let's be honest.

Many CROs bid aggressively.

Especially during competitive proposals.

The initial budget may look attractive.

Then later:

Revenue is recovered through change orders.

This is common in the industry.

Particularly among very large CROs.

Table 2. Typical CRO commercial strategies

Strategy

Sponsor Risk

Low initial bid

High

Aggressive assumptions

High

Narrow scope language

High

Frequent change orders

High

Fixed-fee proposal with exclusions

High

Transparent assumptions

Low

Broad bundled scope

Low

The Biggest Sponsor Mistake

The biggest mistake happens before contract signature.

Sponsors focus on:

Total price.

Instead of:

Assumptions.

I always tell sponsors:

Don't negotiate the budget first.

Negotiate the assumptions first.

Most future change orders originate from assumptions.

Not rates.

Review Every Assumption

Before signing.

Ask the CRO:

How many monitoring visits are included?

How many protocol deviations?

How many database updates?

How many SAE reconciliations?

How many outputs?

How many meetings?

How many medical reviews?

Everything should be clear.

Table 3. Assumptions that frequently trigger change orders

Assumption

Typical Risk

Monitoring frequency

Very High

Enrollment duration

Very High

Number of sites

High

Number of countries

High

Queries per patient

Medium

Protocol amendments

Very High

Number of data transfers

Medium

DSMB meetings

Medium

Statistical outputs

High

CSR revisions

High

Negotiate Protocol Amendment Language

This is one of the most important topics.

Most contracts say:

"Protocol amendments will be billed separately."

This is dangerous.

Because almost every study experiences amendments.

Better Contract Language

For example:

Option A

One amendment included.

No additional fee.

Option B

The first 100 hours of amendment work included.

Option C

Only direct incremental costs billable.

Not overhead.

Not profit markup.

This greatly reduces surprises.

Put Caps on Change Orders

One of my favorite strategies.

Establish caps before the study starts.

Example

Project Management

15% annual variability.

Included.

No change order needed.

Monitoring

10% visit variability.

Included.

No change order needed.

Database Updates

Two minor updates included.

No change order needed.

Table 4. Suggested included buffers

Activity

Recommended Buffer

Monitoring Visits

10-15%

Data Management Hours

10%

Project Management Hours

15%

Safety Activities

10%

Statistical Programming

10%

Medical Writing

10%

Force Transparency

Every change order should contain:

Required Elements

  • Root cause.
  • Scope impact.
  • Resource impact.
  • Budget impact.
  • Timeline impact.
  • Alternative solutions.

Never approve:

"Additional work required."

That statement is meaningless.

Demand specifics.

Ask for Hourly Breakdown

If a CRO requests:

$75,000

Ask:

How many hours?

By whom?

At what rate?

For what tasks?

Table 5. Example change order review

Question

Must Be Answered

Why is change needed?

Yes

Who requested it?

Yes

Is it sponsor-driven?

Yes

Is it CRO-driven?

Yes

Hours required?

Yes

Billing rates?

Yes

Timeline impact?

Yes

Alternative solution available?

Yes

Watch Out for Hidden Scope Exclusions

Read the proposal carefully.

Look for phrases such as:

  • Not included.
  • Assumed.
  • Sponsor responsibility.
  • To be determined.
  • As needed.
  • Future discussion.

These phrases often become future invoices.

Establish Formal Governance

Never let project teams approve change orders directly.

Create a review committee.

Participants should include:

  • Clinical operations.
  • Finance.
  • Procurement.
  • Executive management.

Large sponsors often require approval above predefined thresholds.

For example:

Table 6. Change order approval process

Change Order Value

Approval Level

Under $10,000

Project Lead

$10,000-$50,000

Department Head

$50,000-$100,000

Executive Review

Above $100,000

Senior Management

Benchmark CRO Pricing

Always obtain competing proposals.

Before signing.

Compare:

  • IQVIA
  • ICON
  • Fortrea
  • Parexel
  • Syneos Health
  • Medpace
  • Worldwide Clinical Trials
  • Sofpromed

Do not compare only total cost.

Compare assumptions.

Many sponsors discover one CRO included services another CRO excluded.

That difference later becomes change orders.

Create a Change Order Tracker

Track every change order.

Most sponsors do not.

This is a mistake.

Table 7. Change order dashboard

Metric

Target

Total Number of Change Orders

As Low As Possible

Sponsor-Caused Change Orders

Track

CRO-Caused Change Orders

Track

Total Value

Track

Change Order % of Original Budget

<10% Ideal

Average Approval Time

Monitor

Warning Signs

If a CRO generates:

  • 10 change orders in the first six months.
  • Frequent budget surprises.
  • Repeated assumption disputes.
  • Recurring billing disagreements.

The problem is usually not the study.

The problem is contract management.

Or CRO behavior.

My Top 10 Recommendations

If you remember only ten things:

  1. Negotiate assumptions. Not price.
  2. Define scope in detail.
  3. Include protocol amendment buffers.
  4. Include monitoring buffers.
  5. Include project management buffers.
  6. Require hourly breakdowns.
  7. Challenge vague language.
  8. Create change order approval committees.
  9. Monitor change order metrics monthly.
  10. Select CROs with transparent contracting practices.

Not simply the lowest bid.

Key Takeaways

Most excessive change orders are predictable.

And preventable.

The best sponsors focus on:

  • Detailed scopes.
  • Strong contracts.
  • Transparent assumptions.
  • Strict governance.

Remember this.

A contract is not protection because it is signed.

A contract is protection because it is specific.

The more ambiguity. The more change orders.

The more clarity. The fewer surprises.

Final Words

If you are planning a clinical trial, spend extra time negotiating your CRO contract.

One day of contract review can save hundreds of thousands of dollars later.

And sometimes.

Millions.

Patricio Ledesma

Patricio Ledesma (B.Eng Concordia University, Montreal, Canada and Master’s Degree in Clinical Trials, University of Seville, Spain) is the Head of Clinical Operations and Founder at Sofpromed CRO. Patricio is a professional consultant providing comprehensive, one-stop expert advice and guidance to biotechnology and pharmaceutical companies worldwide in the field of clinical trials and drug development. He is personally and enthusiastically devoted to helping biotech Chief Executive, Operations, Scientific, Medical, and Regulatory Officers in the planning and execution of phase I-IV clinical trials across North America, Europe, Asia-Pacific, Latin America, and Middle East regions. You can contact Patricio at: +34 607 939 266  pledesma@sofpromed.com 

You may also be interested...

Patricio Ledesma

Patricio Ledesma (B.Eng Concordia University, Montreal, Canada and Master’s Degree in Clinical Trials, University of Seville, Spain) is the Head of Clinical Operations and Founder at Sofpromed CRO. Patricio is a professional consultant providing comprehensive, one-stop expert advice and guidance to biotechnology and pharmaceutical companies worldwide in the field of clinical trials and drug development. He is personally and enthusiastically devoted to helping biotech Chief Executive, Operations, Scientific, Medical, and Regulatory Officers in the planning and execution of phase I-IV clinical trials across North America, Europe, Asia-Pacific, Latin America, and Middle East regions. You can contact Patricio at: +34 607 939 266 pledesma@sofpromed.com